Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The product will be commercialized from Unichem's Ghaziabad plant
This further adds to Biocon’s portfolio of vertically integrated complex drug products
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The approval is for Cytomegalovirus, a type of Herpes virus
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
The company is moving towards complex and more differentiated products
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
It is used for the treatment of advanced colorectal and gastric cancer
Nelarabine is in a class of medications called antimetabolites
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
The group now has 324 approvals and has so far filed over 400 ANDAs
Subscribe To Our Newsletter & Stay Updated
